---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-041537"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2026-09-04T20:05:22+00:00"
generated_at: "2026-09-04T20:07:41.759506+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# AIM ImmunoTech converts $1.22M promissory note into 5.07M shares, note satisfied

## Summary
- Converted ~$1,224,341 of Feb 16, 2024 promissory note into 5,065,840 shares at avg $0.24/share.
- Promissory note (original principal $3,301,250) fully satisfied as of Sept 3, 2026; no amounts owing.
- Exchange shares issued under Section 3(a)(9) exemption; no commission or remuneration paid.
- Stockholders approved conversion at July 15, 2026 special meeting per NYSE American rules.
- Shares to be free-trading under Rule 144; holding period tacks to Feb 16, 2024 original note date.

## SEC filing metadata
- accession: 0001493152-26-041537
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2026-09-04T20:05:22+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 1.02, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000149315226041537/0001493152-26-041537-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000149315226041537/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-041537
- JSON: https://secwatch.observer/filing/0001493152-26-041537.json
- Plain text: https://secwatch.observer/filing/0001493152-26-041537.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.